Clarification, 10/7/14, 4 p.m.: This story has been revised to clarify Weil, Gotshal & Manges’ role in advising Goldman Sachs & Co. The story also now includes lawyers from Epstein Becker & Green, which provided BD with health regulatory counsel.
Medical technology company Becton, Dickinson and Co. is buying medical-device maker CareFusion Corp. for $12.2 billion in cash and stock, marking the latest in a record-setting series of mergers and acquisitions in the pharmaceutical and medical device manufacturing industries following health care reform in the U.S. under the Affordable Care Act.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
